--- title: "About DeLande Group | Technology-Enabled Logistics" url: https://delandegroupholdings.com/about description: "DeLande Group Holdings is a technology-driven logistics company specializing in last-mile distribution for underserved populations and complex markets." lang: en --- About Us # The operating layer for the pharmaceutical supply chain DeLande Group is the operating layer for the pharmaceutical supply chain in hard-to-reach markets, built from real-world operations. We run live operations in rural and underserved markets, and we're building VerKairos, the software that makes them predictable. Our Story ## Built from Real Operations Incorporated in 2018. We spent the early years on formation, licensing and state registrations, then went live in the U.S. Virgin Islands. Our St. Croix operations center is where VerKairos is being shaped. Headquartered in New York. ### What we run today - Pharmaceutical logistics - Medical supplies distribution - Cold chain management - Essential commodities distribution - Technology-enabled supply chain solutions For clients who require reliable service in underserved markets. Our Values ## Core Operating Principles ### Market Access We develop operating infrastructure that eliminates geographic and infrastructural barriers to essential goods distribution, enabling consistent market access regardless of location. ### Innovation We continuously develop advanced logistics solutions to solve complex distribution challenges in resource-constrained environments. ### Operational Excellence We maintain rigorous service-level commitments through precision execution, validated processes, and continuous performance optimization across all markets we serve. ### Sustainable Operations Our operations prioritize carbon footprint reduction and strategic local partnerships that generate long-term value for stakeholders and communities. Our Journey ## Key Milestones 2018 ### Incorporated Incorporated in New York. 2023 ### St. Croix Operations Center St. Croix operations center launched. 2024 ### First Live Shipments First live shipments. 2026 ### VerKairos Prototype VerKairos prototype built. What We Do ## Live Operations in Challenging Markets Our approach is built on execution in markets where traditional infrastructure is limited. ### The operation VerKairos is built from ### Pharmaceutical Distribution OTC medicines, medical supplies, and healthcare products with strict regulatory compliance. ### Cold Chain Management Validated cold chain infrastructure ensuring product integrity in regions with inconsistent power. ### Warehouse Management FEFO protocols across ambient and controlled-temperature storage with continuous monitoring. ### Last-Mile Distribution Specialized delivery networks for remote healthcare facilities and isolated communities. ### Service Capabilities Our pharmaceutical distribution operations specialize in Over-the-Counter medicines, medical supplies, and healthcare products requiring strict regulatory compliance and quality controls. Through validated cold chain infrastructure, we ensure product integrity throughout the supply chain, including in regions with inconsistent power and transportation infrastructure. Our warehouse management systems implement First Expiration, First Out (FEFO) protocols across both ambient and controlled-temperature storage environments. All facilities maintain compliance with international pharmaceutical standards through continuous monitoring and documented quality assurance protocols. Leadership ## Executive Team Our leadership combines deep domain expertise in regulated pharmaceutical operations, enterprise technology development, and operational excellence in complex markets. ### Carla DeLande Chief Executive Officer Extensive expertise in regulated industries and complex market operations. Leads strategic direction and enterprise growth initiatives. ### Adegboyega Akinsiku Chief Technology Officer Oversees technology development and infrastructure scalability. ### Nancy Brutus Medical Director Licensed clinician responsible for clinical standards, regulatory compliance frameworks, and pharmaceutical quality assurance across all operations. Our Approach ## Solving Complex Logistics Challenges Through Technology Underserved markets require specialized infrastructure, regulatory expertise, and operational models that account for unique market constraints. Our approach combines advanced logistics solutions with localized operational knowledge to deliver consistent, reliable results. Whether deploying pharmaceutical distribution to remote healthcare facilities, establishing retail supply chains in isolated communities, or building distribution networks in previously unserved markets, DeLande Group applies systematic problem-solving, advanced technology, and specialized domain expertise to each engagement. ### How We Measure Success #### Operational Metrics Precision execution and process optimization #### Service-Level Performance Rigorous commitment tracking and delivery #### Market Penetration Expanding access to underserved populations #### Sustainable Value Creation Long-term stakeholder and community impact ### DeLande Group Holdings New York Headquarters | St. Croix Operations Center | Global Operations Network Technology-enabled logistics solutions for underserved markets worldwide.